Wednesday, October 29, 2008 10:05:09 AM
Sales for the first quarter of fiscal 2009 amounted to $11,263,000 compared to $14,336,000 in last year’s first quarter. Income from continuing operations amounted to $2,280,000 ($0.27 per share) compared to $3,295,000 ($0.38 per share) last year and net income amounted to $2,280,000 ($0.27 per share) this year compared to $3,455,000 ($0.40 per share) last year.
Raymond M. Soto, Bolt’s chairman, president and CEO, commented, “During the first quarter of fiscal 2009, our sales decreased 21% from the first quarter of fiscal 2008 principally due to a decrease in sales of new energy sources (air guns). Sales of air guns decreased about 50% from last year but this was partially offset by a 33% increase in sales of underwater connectors and seismic source controllers.” Mr. Soto added, “Our current financial position remains solid with over $20,000,000 in cash and cash equivalents, over $41,000,000 in working capital and no debt. We continue to experience active customer inquiries and we remain cautiously optimistic that fiscal 2009 will be a good year for our Company. However, a reduction in worldwide exploration spending as a result of the recent turmoil in the world credit markets and/or a decrease in the demand for oil which could result from a severe economic downturn, would undoubtedly have an effect on our business.” Bolt Technology Corporation is a leading worldwide developer and manufacturer of oilfield services equipment, including seismic energy sources, seismic source controllers and synchronizers and underwater connectors used in the offshore seismic exploration for oil and gas.
Recent BOLT News
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/12/2026 08:14:51 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/12/2026 08:07:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/12/2026 08:05:29 PM
- Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Business Update • GlobeNewswire Inc. • 03/12/2026 08:05:00 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 02/27/2026 12:22:05 AM
- Bolt Biotherapeutics to Participate in Upcoming March Conferences • GlobeNewswire Inc. • 02/24/2026 01:00:00 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 02/18/2026 01:11:16 AM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/13/2026 11:48:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2026 09:32:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2026 09:32:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/16/2025 10:14:10 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 09:08:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 09:05:28 PM
- Bolt Biotherapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update • GlobeNewswire Inc. • 11/12/2025 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/24/2025 11:19:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/24/2025 11:18:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2025 08:05:26 PM
- Bolt Biotherapeutics Provides Update on BDC-4182 and Extends Cash Runway into 2027 • GlobeNewswire Inc. • 10/01/2025 08:05:00 PM
- Bolt Biotherapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update • GlobeNewswire Inc. • 08/14/2025 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/02/2025 08:05:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/06/2025 08:39:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2025 08:05:10 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/12/2025 08:08:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/12/2025 08:05:11 PM
- Bolt Biotherapeutics Reports First Quarter 2025 Financial Results and Provides Business Update • GlobeNewswire Inc. • 05/12/2025 08:05:00 PM
FEATURED Cannabix Technologies Announces Commercial Launch of Marijuana Breath Test (MBT) • Mar 16, 2026 8:37 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
